Bailey D L, Adams G G, Tsao C E, Hyslop A, Escobar K, Manton D J, Reynolds E C, Morgan M V
Centre for Oral Health Science, Melbourne Dental School, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, 720 Swanston Street, Victoria, 3010, Australia.
J Dent Res. 2009 Dec;88(12):1148-53. doi: 10.1177/0022034509347168. Epub 2009 Nov 3.
Orthodontic patients have an increased risk of white-spot lesion formation. A clinical trial was conducted to test whether, in a post-orthodontic population using fluoride toothpastes and receiving supervised fluoride mouthrinses, more lesions would regress in participants using a remineralizing cream containing casein phosphopeptide- amorphous calcium phosphate compared with a placebo. Forty-five participants (aged 12-18 yrs) with 408 white-spot lesions were recruited, with 23 participants randomized to the remineralizing cream and 22 to the placebo. Product was applied twice daily after fluoride toothpaste use for 12 weeks. Clinical assessments were performed according to ICDAS II criteria. Transitions between examinations were coded as progressing, regressing, or stable. Ninety-two percent of lesions were assessed as code 2 or 3. For these lesions, 31% more had regressed with the remineralizing cream than with the placebo (OR = 2.3, P = 0.04) at 12 weeks. Significantly more post-orthodontic white-spot lesions regressed with the remineralizing cream compared with a placebo over 12 weeks.
正畸患者发生白斑病变的风险增加。开展了一项临床试验,以测试在使用含氟牙膏并接受监督下氟漱口水的正畸后人群中,与使用安慰剂相比,使用含酪蛋白磷酸肽 - 无定形磷酸钙的再矿化乳膏的参与者中是否有更多病变会消退。招募了45名(年龄在12 - 18岁)有408处白斑病变的参与者,其中23名参与者被随机分配至再矿化乳膏组,22名被分配至安慰剂组。在使用含氟牙膏后,每天两次涂抹产品,持续12周。根据ICDAS II标准进行临床评估。检查之间的转变被编码为进展、消退或稳定。92%的病变被评估为2级或3级。对于这些病变,在12周时,使用再矿化乳膏的病变消退比例比使用安慰剂的多31%(比值比 = 2.3,P = 0.04)。与安慰剂相比,在12周内,正畸后白斑病变使用再矿化乳膏消退的比例显著更高。